Developer docs
API playgroundTry for free, no card

Search company profiles

Germano de Sousa

Full company profile

uuid000lslp

Namestring
Germano de Sousa
Legal namestring
Centro de Medicina Laboratorial Germano de Sousa, S.A.
Company typeenum
Private
Founded yearint
1976
Descriptiontext

Germano de Sousa is a Portuguese clinical pathology laboratory group founded in 1976 by Prof. Doutor Germano de Sousa. The group operates three specialized laboratories covering Clinical Pathology, Anatomical Pathology, and Genetics, supported by more than 500 patient collection points across continental Portugal and the Azores, and serves over one million patients annually. The company holds regulatory accreditation through ERS (Entidade Reguladora da Saúde) and the My Green Lab certification, and operates under the Serene® trademark for its non-invasive prenatal test.

The core offering spans routine clinical analysis alongside higher-value specialty diagnostics including the Serene NIPT (non-invasive prenatal testing), Gut Health Premium microbiome panels, Avantect pancreatic cancer screening, Alzheimer's biomarker testing, and COVID-19 testing. Revenue is generated through recurring clinical-pathology, genetics, and anatomical-pathology subscriptions on the patient-facing side, and through professional-services contracts for occupational medicine and home collection services. On the B2B side, the group contracts with Portugal's National Health Service (SNS/ARS), private insurers, and corporate clients.

Distribution is anchored on the 500+ physical collection points and increasingly supplemented by home-collection services and dedicated digital channels per specialty. The company maintains research collaborations with INOV INESC, Nova Medical School, EIA, and V4H, and has participated in EU-funded innovation projects including BE4YOU (€1.25M), a COVID-19 R&D and automation program (€400K), and a Productive Innovation initiative (€160K). The group remains privately held and founder-influenced, with no disclosed PE/VC backing or public-market listing.

Short descriptiontext

Founded in 1976, Germano de Sousa is Portugal's largest clinical pathology laboratory group, operating 500+ collection points across continental Portugal and the Azores and serving over one million patients annually through clinical analysis, genetics, anatomical pathology, and specialized diagnostic testing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersCarnide, Portugal
HQ citystring
Carnide
HQ countrystring
Portugal
HQ regionstring
Europe
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, prenatal screening tests, anatomical pathology services, genetic testing services, occupational health testing
Industry5 codes
1Anatomic Pathology (Histopathology & Cytopathology)
CodeHLAFAMAAPrimaryYes
2Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryNo
3Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
CodeHLAAAMACPrimaryNo
4Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs
CodeHLACAMAHPrimaryNo
5Microbiology & Infectious Disease Testing (Trial Support)
CodeHLAGAEAFPrimaryNo
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Health Services8000
Product category
Clinical Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Clinical Pathology Testing Services
TypeSubscription Recurring
Description

Core laboratory testing services including blood tests, urine analysis, and other clinical pathology examinations performed at main laboratories and collection points. Revenue generated through patient payments, health insurance reimbursements, and SNS/ARS subsystem agreements.

germanodesousa.com:443
2Genetic Testing Services
TypeSubscription Recurring
Description

Specialized genetic testing including prenatal screening (Serene® NIPT), hereditary disease testing, and cancer genetic testing.

germanodesousa.com:443
3Anatomical Pathology Services
TypeSubscription Recurring
Description

Tissue analysis and pathological examination services.

germanodesousa.com:443
4Occupational Medicine Services
TypeProfessional Services
Description

Company occupational health programs including workplace medical examinations and testing for businesses.

germanodesousa.com:443
5Home Collection Services
TypeProfessional Services
Description

At-home sample collection services for patients with mobility limitations or preference for home service.

germanodesousa.com:443
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1Standard clinical analysis services
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Services billed through health insurance subsystems (SNS/ARS), private insurance, and direct patient payment. Specific prices not publicly listed on website.

germanodesousa.com:443
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Centro de Medicina Laboratorial Germano de Sousa
Description

Primary clinical pathology laboratory services division

germanodesousa.com:443
+3 more records
Core offering1 text field

Germano de Sousa is a Portuguese clinical pathology laboratory group that delivers diagnostic testing services through a national network of more than 500 patient collection points and three specialized laboratories covering clinical pathology, anatomical pathology, and genetics. Core services include routine clinical analyses, prenatal screening (including NIPT), cytogenetics and genomics research, and anatomopathological diagnostics, with additional corporate occupational health testing and partnerships with the Portuguese National Health Service (SNS) and private insurers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • >99% sensitivity for trisomy 21, 18, and 13 detection in prenatal screening
+2 more records
Product overview1 text field

Germano de Sousa is a Portuguese clinical laboratory group operating under three core sub-brands: Centro de Medicina Laboratorial (Clinical Pathology Laboratory), Centro de Anatomia Patológica (Anatomical Pathology Laboratory), and Laboratório de Genética (Genetics Laboratory). The group provides a broad portfolio of diagnostic and laboratory services centered on its clinical analysis offering, supplemented by specialized modules including the Gut Health Premium microbiome test, the Serene® non-invasive prenatal screening (NIPT) test, and the Avantect pancreatic cancer early-detection blood test. Services are delivered through a national network of over 500 collection points, with at-home collection, occupational health, and cardiology services as additional modules. Patients access results through online portals and email delivery. The group also operates educational and community initiatives including the No Lab Com and ABC da Genética podcasts, the Programa Escolas school outreach program, a dedicated pregnancy portal (Site da Grávida), and publishes an annual Clinical Cases Book. Founded 50 years ago, the group processes millions of laboratory tests annually serving over one million patients per year.

Product and service1 record
1Clinical pathology laboratory testing
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-12-09
Description

Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Project code LISBOA-01-0247-FEDER-046993 and CENTRO-01-0247-FEDER-046993. Total eligible cost €1,247,331.12 with EU FEDER funding of €707,940.68.

2INOV INESC (INESC INOVAÇÃO)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-12-09
Description

Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Project focused on active prevention and promotion of adequate habits and behaviors for adults (+45 years).

germanodesousa.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-12-09
Description

Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Part of consortium developing innovative services platform for community health.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-12-09
Description

Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Part of consortium developing innovative services platform for community health.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-10-15
Description

COVID-19 R&D project (LISBOA-01-02B7-FEDER-069202) in collaboration with V4H Association. Total eligible cost €399,641.04 with EU FEDER funding of €319,712.83. Project created national serological screening network and studied SARS-CoV-2 seroprevalence in Portuguese population.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-10-15
Description

COVID-19 R&D partnership focused on implementing national SARS-CoV-2 exposure screening strategy with high-sensitivity tests and reference laboratory capacity for public health decision support.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Joint partnership with Mustela for maternal and baby care. The collaboration focuses on caring for expectant mothers, new mothers, and babies in their dermatological care needs. Project includes a dedicated 'Kit Mustela Germano de Sousa' available at select collection points.

8Various Clinics and Pharmacies
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

500+ collection points operated through partnerships with independent pharmacies, medical clinics, and healthcare facilities across Portugal. These partners host collection services under the Germano de Sousa brand.

germanodesousa.com:443
9SNS/ARS (National Health Service and Regional Health Administrations)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Public healthcare subsystem agreements allowing patients to access Germano de Sousa laboratory services through national health coverage.

germanodesousa.com:443
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Insurance reimbursement agreements with private health insurance providers for laboratory testing services covered under patient policies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global clinical laboratory and drug development services company with extensive specialty testing capabilities in genetics, oncology, and companion diagnostics. Comparable to Germano de Sousa's advanced test menu (NIPT, ctDNA, biomarker analysis) at significantly larger scale.

2CUF
TypeBroad incumbent
Description

Largest Portuguese private healthcare group operating hospitals, clinics, and in-house laboratory services. While primarily a hospital operator, CUF's captive diagnostics unit competes with Germano de Sousa for physician referrals, specialty testing, and enterprise occupational health contracts in Portugal.

TypeDirect peer
Description

Portuguese clinical laboratory and diagnostics operator offering clinical analysis, imaging, and occupational medicine services. Most direct domestic peer to Germano de Sousa in Portugal, with overlapping collection networks, hospital partnerships, and patient referral channels.

TypeBroad incumbent
Description

Europe's largest clinical laboratory operator with pan-European network across 30+ countries, including Iberia. Overlaps directly with Germano de Sousa on routine clinical pathology, genetic testing, and occupational medicine, but at significantly larger scale and with broader specialty test menus.

TypeBroad incumbent
Description

U.S. clinical laboratory leader with growing international footprint through acquired specialty labs. Overlaps with Germano de Sousa on advanced genetic and molecular diagnostics (NIPT, oncology) and serves as a reference point for specialty test pricing and menu development.

TypeDirect peer
Description

Portuguese anatomical pathology laboratory specializing in histopathology and cytology. Direct competitor within Germano de Sousa's Anatomic Pathology division, serving overlapping physician referral networks in Portugal.

TypeBroad incumbent
Description

Global clinical laboratory and radiology operator with European operations including Germany, Switzerland, and the UK. Comparable to Germano de Sousa in clinical pathology scale and specialty testing, but operating as a publicly-listed multinational with broader geographic reach.

TypeEmerging player
Description

Genetics and molecular diagnostics specialty lab within the Eurofins network, operating across Southern Europe. Direct overlap with Germano de Sousa's genetics division on NIPT, hereditary disease testing, and prenatal screening with comparable test panels.

TypeBroad incumbent
Description

European diagnostics and outpatient imaging operator with Iberian footprint. Overlaps with Germano de Sousa on advanced diagnostics and preventive health screening for corporate and public-payor clients across Portugal and Spain.

TypeBroad incumbent
Description

Major European clinical diagnostics and imaging network with presence in Portugal and Spain. Competes with Germano de Sousa in routine lab testing, specialty diagnostics, and corporate occupational health, with stronger cross-border integration and capital backing from private equity sponsors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Germano de Sousa

Clinical Laboratory Servicesgermanodesousa.com

Founded in 1976, Germano de Sousa is Portugal's largest clinical pathology laboratory group, operating 500+ collection points across continental Portugal and the Azores and serving over one million patients annually through clinical analysis, genetics, anatomical pathology, and specialized diagnostic testing services.

What Germano de Sousa does

Germano de Sousa is a Portuguese clinical pathology laboratory group founded in 1976 by Prof. Doutor Germano de Sousa. The group operates three specialized laboratories covering Clinical Pathology, Anatomical Pathology, and Genetics, supported by more than 500 patient collection points across continental Portugal and the Azores, and serves over one million patients annually. The company holds regulatory accreditation through ERS (Entidade Reguladora da Saúde) and the My Green Lab certification, and operates under the Serene® trademark for its non-invasive prenatal test.

The core offering spans routine clinical analysis alongside higher-value specialty diagnostics including the Serene NIPT (non-invasive prenatal testing), Gut Health Premium microbiome panels, Avantect pancreatic cancer screening, Alzheimer's biomarker testing, and COVID-19 testing. Revenue is generated through recurring clinical-pathology, genetics, and anatomical-pathology subscriptions on the patient-facing side, and through professional-services contracts for occupational medicine and home collection services. On the B2B side, the group contracts with Portugal's National Health Service (SNS/ARS), private insurers, and corporate clients.

Distribution is anchored on the 500+ physical collection points and increasingly supplemented by home-collection services and dedicated digital channels per specialty. The company maintains research collaborations with INOV INESC, Nova Medical School, EIA, and V4H, and has participated in EU-funded innovation projects including BE4YOU (€1.25M), a COVID-19 R&D and automation program (€400K), and a Productive Innovation initiative (€160K). The group remains privately held and founder-influenced, with no disclosed PE/VC backing or public-market listing.

Germano de Sousa firmographics

Firmographics
Name
Germano de Sousa
Legal name
Centro de Medicina Laboratorial Germano de Sousa, S.A.
Website
https://germanodesousa.com
Company type
Private
Founded year
1976
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Founded in 1976, Germano de Sousa is Portugal's largest clinical pathology laboratory group, operating 500+ collection points across continental Portugal and the Azores and serving over one million patients annually through clinical analysis, genetics, anatomical pathology, and specialized diagnostic testing services.
Ownership category
akta.pro rank

Germano de Sousa industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), Services-Health Services (8000)
akta.pro primary industry
Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
akta.pro secondary industries
Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs (HLACAMAH), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

  • Clinical laboratory services
  • Prenatal screening tests
  • Anatomical pathology services
  • Genetic testing services
  • Occupational health testing

Where Germano de Sousa is headquartered

Location

Headquarters

HQ city
Carnide
HQ country
Portugal
HQ region
Europe

Offices11 records

Markets served

Germano de Sousa business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical Pathology Testing Services: Core laboratory testing services including blood tests, urine analysis, and other clinical pathology examinations performed at main laboratories and collection points. Revenue generated through patient payments, health insurance reimbursements, and SNS/ARS subsystem agreements.
  2. Genetic Testing Services: Specialized genetic testing including prenatal screening (Serene® NIPT), hereditary disease testing, and cancer genetic testing.
  3. Anatomical Pathology Services: Tissue analysis and pathological examination services.
  4. Occupational Medicine Services: Company occupational health programs including workplace medical examinations and testing for businesses.
  5. Home Collection Services: At-home sample collection services for patients with mobility limitations or preference for home service.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goStandard clinical analysis services

Go-to-market motion2 records

Distribution channels7 records

Marketing channels8 records

Germano de Sousa product offering

Product offering

Core offering

Germano de Sousa is a Portuguese clinical pathology laboratory group that delivers diagnostic testing services through a national network of more than 500 patient collection points and three specialized laboratories covering clinical pathology, anatomical pathology, and genetics. Core services include routine clinical analyses, prenatal screening (including NIPT), cytogenetics and genomics research, and anatomopathological diagnostics, with additional corporate occupational health testing and partnerships with the Portuguese National Health Service (SNS) and private insurers.

Product overview

Germano de Sousa is a Portuguese clinical laboratory group operating under three core sub-brands: Centro de Medicina Laboratorial (Clinical Pathology Laboratory), Centro de Anatomia Patológica (Anatomical Pathology Laboratory), and Laboratório de Genética (Genetics Laboratory). The group provides a broad portfolio of diagnostic and laboratory services centered on its clinical analysis offering, supplemented by specialized modules including the Gut Health Premium microbiome test, the Serene® non-invasive prenatal screening (NIPT) test, and the Avantect pancreatic cancer early-detection blood test. Services are delivered through a national network of over 500 collection points, with at-home collection, occupational health, and cardiology services as additional modules. Patients access results through online portals and email delivery. The group also operates educational and community initiatives including the No Lab Com and ABC da Genética podcasts, the Programa Escolas school outreach program, a dedicated pregnancy portal (Site da Grávida), and publishes an annual Clinical Cases Book. Founded 50 years ago, the group processes millions of laboratory tests annually serving over one million patients per year.

Differentiator

Problem solved

Functional benefit

Brands

  • Centro de Medicina Laboratorial Germano de Sousa: Primary clinical pathology laboratory services division
  • Centro de Anatomia Patológica
  • Centro de Genética Laboratorial
  • Site da Grávida

Products and services

  • Clinical pathology laboratory testing

Quantifiable outcome

  • >99% sensitivity for trisomy 21, 18, and 13 detection in prenatal screening
  • +2 more outcomes

Companies that use Germano de Sousa

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Germano de Sousa technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Germano de Sousa partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered minor and core.

  • AgileFactorminorStrategic or Co-development Partner · 9 December 2021Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Project code LISBOA-01-0247-FEDER-046993 and CENTRO-01-0247-FEDER-046993. Total eligible cost €1,247,331.12 with EU FEDER funding of €707,940.68.
  • INOV INESC (INESC INOVAÇÃO)minorStrategic or Co-development Partner · 9 December 2021Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Project focused on active prevention and promotion of adequate habits and behaviors for adults (+45 years).
  • EIA (Entity)minorStrategic or Co-development Partner · 9 December 2021Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Part of consortium developing innovative services platform for community health.
  • SegursalminorStrategic or Co-development Partner · 9 December 2021Partnership in BE4YOU project: Predictive platform for health and well-being analysis. Part of consortium developing innovative services platform for community health.
  • Universidade Nova de Lisboa – Nova Medical School – Faculdade de Ciências Médicas (NMS-FCM)minorStrategic or Co-development Partner · 15 October 2020COVID-19 R&D project (LISBOA-01-02B7-FEDER-069202) in collaboration with V4H Association. Total eligible cost €399,641.04 with EU FEDER funding of €319,712.83. Project created national serological screening network and studied SARS-CoV-2 seroprevalence in Portuguese population.
  • V4H – Associação para a investigação em valor e inovação tecnológica em saúdeminorStrategic or Co-development Partner · 15 October 2020COVID-19 R&D partnership focused on implementing national SARS-CoV-2 exposure screening strategy with high-sensitivity tests and reference laboratory capacity for public health decision support.
  • MustelaminorGTM or Marketing PartnerJoint partnership with Mustela for maternal and baby care. The collaboration focuses on caring for expectant mothers, new mothers, and babies in their dermatological care needs. Project includes a dedicated 'Kit Mustela Germano de Sousa' available at select collection points.
  • Various Clinics and PharmaciescoreChannel Partner/ Reseller/ Distributor500+ collection points operated through partnerships with independent pharmacies, medical clinics, and healthcare facilities across Portugal. These partners host collection services under the Germano de Sousa brand.
  • SNS/ARS (National Health Service and Regional Health Administrations)coreChannel Partner/ Reseller/ DistributorPublic healthcare subsystem agreements allowing patients to access Germano de Sousa laboratory services through national health coverage.
  • Private Health Insurance CompaniescoreChannel Partner/ Reseller/ DistributorInsurance reimbursement agreements with private health insurance providers for laboratory testing services covered under patient policies.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Germano de Sousa competitors and assessment

Company assessment

Broad incumbents

  • Labcorp: Global clinical laboratory and drug development services company with extensive specialty testing capabilities in genetics, oncology, and companion diagnostics. Comparable to Germano de Sousa's advanced test menu (NIPT, ctDNA, biomarker analysis) at significantly larger scale.
  • CUF: Largest Portuguese private healthcare group operating hospitals, clinics, and in-house laboratory services. While primarily a hospital operator, CUF's captive diagnostics unit competes with Germano de Sousa for physician referrals, specialty testing, and enterprise occupational health contracts in Portugal.
  • Synlab: Europe's largest clinical laboratory operator with pan-European network across 30+ countries, including Iberia. Overlaps directly with Germano de Sousa on routine clinical pathology, genetic testing, and occupational medicine, but at significantly larger scale and with broader specialty test menus.
  • Quest Diagnostics: U.S. clinical laboratory leader with growing international footprint through acquired specialty labs. Overlaps with Germano de Sousa on advanced genetic and molecular diagnostics (NIPT, oncology) and serves as a reference point for specialty test pricing and menu development.
  • Sonic Healthcare: Global clinical laboratory and radiology operator with European operations including Germany, Switzerland, and the UK. Comparable to Germano de Sousa in clinical pathology scale and specialty testing, but operating as a publicly-listed multinational with broader geographic reach.
  • Affidea: European diagnostics and outpatient imaging operator with Iberian footprint. Overlaps with Germano de Sousa on advanced diagnostics and preventive health screening for corporate and public-payor clients across Portugal and Spain.
  • Unilabs: Major European clinical diagnostics and imaging network with presence in Portugal and Spain. Competes with Germano de Sousa in routine lab testing, specialty diagnostics, and corporate occupational health, with stronger cross-border integration and capital backing from private equity sponsors.

Direct peers

  • Joaquim Chaves Saúde: Portuguese clinical laboratory and diagnostics operator offering clinical analysis, imaging, and occupational medicine services. Most direct domestic peer to Germano de Sousa in Portugal, with overlapping collection networks, hospital partnerships, and patient referral channels.
  • Dr. Campos Costa: Portuguese anatomical pathology laboratory specializing in histopathology and cytology. Direct competitor within Germano de Sousa's Anatomic Pathology division, serving overlapping physician referral networks in Portugal.

Emerging players

  • Eurofins Genoma: Genetics and molecular diagnostics specialty lab within the Eurofins network, operating across Southern Europe. Direct overlap with Germano de Sousa's genetics division on NIPT, hereditary disease testing, and prenatal screening with comparable test panels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Germano de Sousa social profiles

Digital presence

Germano de Sousa compliance and trust

Trust signal

Compliance2 records

Germano de Sousa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Germano de Sousa leadership team

Management profile

Number of profiles

Profiles1 record

Germano de Sousa funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Germano de Sousa M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Germano de Sousa

What does Germano de Sousa do?

Germano de Sousa is a Portuguese clinical pathology laboratory group that delivers diagnostic testing services through a national network of more than 500 patient collection points and three specialized laboratories covering clinical pathology, anatomical pathology, and genetics. Core services include routine clinical analyses, prenatal screening (including NIPT), cytogenetics and genomics research, and anatomopathological diagnostics, with additional corporate occupational health testing and partnerships with the Portuguese National Health Service (SNS) and private insurers.

Is Germano de Sousa a public or private company?

Germano de Sousa is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Germano de Sousa founded?

Germano de Sousa was founded in 1976. It employs 1,001 to 5,000 people.

Where is Germano de Sousa based?

Germano de Sousa is headquartered in Carnide, Portugal, in the Europe region.

How does Germano de Sousa make money?

Five revenue lines are on record. Clinical Pathology Testing Services are the primary driver. The others are genetic Testing Services, anatomical Pathology Services, occupational Medicine Services and home Collection Services.

Who are Germano de Sousa's main competitors?

Broad incumbents on record are Labcorp, CUF, Synlab, Quest Diagnostics, Sonic Healthcare, Affidea and Unilabs. Direct peers are Joaquim Chaves Saúde and Dr. Campos Costa. Eurofins Genoma is listed as an emerging player.

Does Germano de Sousa have an API?

No public API is recorded for Germano de Sousa.

What industry is Germano de Sousa in?

Germano de Sousa's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales